Inactive/Delisted stock
Unicycive Therapeutics Stock (NASDAQ:UNCY)
Previous Close
$4.09
52W Range
$3.40 - $11.00
50D Avg
$4.43
200D Avg
$5.82
Market Cap
$49.41M
Avg Vol (3M)
$709.75K
Beta
1.86
Div Yield
-
UNCY Company Profile
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.